Stay updated on Milademetan Safety in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now shows a 403 error, replacing the previous detailed study content with an access-denied message. The change removes the rich study data and presents an error state instead.SummaryDifference21%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a website/software update rather than any modification to the study content.SummaryDifference0.0%

- Check49 days agoChange DetectedPublications section updated to include a Phase 1 milademetan dose-escalation study citation and a note that publications are automatically filled from PubMed. PubMed-derived entries may not all be about this study.SummaryDifference0.2%

- Check57 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5, indicating a maintenance release. No study information or page functionality appears to be affected.SummaryDifference0.0%

- Check71 days agoChange DetectedFooter revision updated from v3.6.3 to v3.6.4, indicating a new page build was deployed.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This is an administrative revision label update without substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.